BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 120 filers reported holding BIOSCRIP INC in Q3 2016. The put-call ratio across all filers is 0.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $959,000 | +667.2% | 368,700 | +953.4% | 0.01% | +500.0% |
| Q4 2018 | $125,000 | -79.1% | 35,000 | -81.9% | 0.00% | -66.7% |
| Q3 2018 | $598,000 | -16.0% | 192,900 | -20.6% | 0.01% | -14.3% |
| Q2 2018 | $712,000 | +49.9% | 242,900 | +25.9% | 0.01% | +40.0% |
| Q1 2018 | $475,000 | -49.0% | 192,900 | -39.7% | 0.01% | -50.0% |
| Q4 2017 | $931,000 | +5.8% | 319,900 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $880,000 | -37.2% | 319,900 | -38.0% | 0.01% | -41.2% |
| Q2 2017 | $1,402,000 | +125.0% | 516,238 | +41.0% | 0.02% | +112.5% |
| Q1 2017 | $623,000 | +974.1% | 366,238 | +558.3% | 0.01% | +700.0% |
| Q4 2016 | $58,000 | -93.6% | 55,638 | -82.2% | 0.00% | -92.3% |
| Q3 2016 | $904,000 | +13.3% | 312,900 | 0.0% | 0.01% | +8.3% |
| Q2 2016 | $798,000 | +22.2% | 312,900 | +2.6% | 0.01% | +9.1% |
| Q1 2016 | $653,000 | +62.0% | 305,000 | +32.6% | 0.01% | +57.1% |
| Q4 2015 | $403,000 | -6.3% | 230,000 | 0.0% | 0.01% | -22.2% |
| Q3 2015 | $430,000 | -25.3% | 230,000 | +559.0% | 0.01% | -60.9% |
| Q2 2013 | $576,000 | – | 34,900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venor Capital Management LP | 12,005,453 | $20,409,000 | 10.92% |
| Coliseum Capital Management, LLC | 5,622,410 | $9,558,000 | 4.30% |
| Alta Fundamental Advisers LLC | 2,217,164 | $3,769,000 | 4.07% |
| WYNNEFIELD CAPITAL INC | 3,800,000 | $6,460,000 | 2.37% |
| ARDSLEY ADVISORY PARTNERS LP | 5,280,000 | $8,976,000 | 1.40% |
| NORTH TIDE CAPITAL, LLC | 3,000,000 | $5,100,000 | 0.78% |
| Camber Capital Management LP | 10,180,000 | $17,306,000 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 310,500 | $528,000 | 0.54% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 233,280 | $397,000 | 0.19% |
| Eidelman Virant Capital | 140,000 | $238,000 | 0.16% |